Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fluoride-free cavity fighter?

This article was originally published in The Tan Sheet

Executive Summary

Ortek Therapeutics has "begun its formal pursuit" of new drug applications for two new Rx products containing CaviStat, a cavity-fighting complex that mimics saliva's anti-cavity properties, the firm says July 11. Cavistat contains arginine, the common amino acid that neutralizes erosive acids while strengthening and repairing the tooth structure with calcium carbonate and bicarbonate, the firm states. Ortek hopes to have DenClude Desensitizing Dental Cream approved as the first flouride-free cavity fighting toothpaste in the world. The product already is an Rx toothpaste indicated for the management of tooth sensitivity. The firm also is pursuing approval of BasicMints as the first cavity-fighting confection available to consumers worldwide. While fluoride helps to remineralize teeth, it can have toxic side effects and lead to bone fractures after prolonged use, Ortek maintains. The firm says it will eventually pursue OTC status for the products...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel